These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4976851)

  • 41. Clinical pharmacology of aminocaproic and tranexamic acids.
    Nilsson IM
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():41-7. PubMed ID: 7000846
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of para-aminomethylbenzoic acid on the post-irradiation disturbance of haemocoagulation in dogs after whole-body exposure to 600 R.
    Pospísil J; Skala E; Vranovská J; Dienstbier Z
    Strahlentherapie; 1972 Dec; 144(6):728-36. PubMed ID: 4567740
    [No Abstract]   [Full Text] [Related]  

  • 43. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA].
    Fischer M
    Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of various hemostyptics in animal experiment].
    Mergard U; Köhnlein HE
    Chirurg; 1972 Sep; 43(9):411-5. PubMed ID: 5080381
    [No Abstract]   [Full Text] [Related]  

  • 45. [Fibrinolytic activity of the wall of veins].
    Büttner D; Schmidt FC
    Vasa; 1972; 1(1):24-8. PubMed ID: 4260129
    [No Abstract]   [Full Text] [Related]  

  • 46. [Atrio-ventricular and intraventricular conduction after administration of trimethoxy-benzoyl- -aminocaproic acid in man].
    Masini G; Gherardi C; Dianda R
    Cardiol Prat; 1973; 24(1):73-8. PubMed ID: 4709175
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fibrinolytic inhibitors].
    Nagamatsu A
    Saishin Igaku; 1966 Feb; 21(2):320-5. PubMed ID: 5966316
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacological study of some inhibitors of fibrinolysis].
    Gavrilov AP
    Farmakol Toksikol; 1967; 30(4):460-3. PubMed ID: 5598902
    [No Abstract]   [Full Text] [Related]  

  • 49. [Method of determination of fibrinolysis inhibitors in biological material].
    Richter M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):123-7. PubMed ID: 4173873
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of fibrinolytics and antifibrinolytics on wound healing. Experimental study].
    Wilde J; Ampt HJ
    Z Exp Chir; 1971; 4(4):241-7. PubMed ID: 5317395
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative study of the enzyme activity and inhibition of terrilytin and proteases with thrombolytic activity].
    Selezneva AA; Kozlova TA; Samsonov GV
    Prikl Biokhim Mikrobiol; 1972; 8(5):526-31. PubMed ID: 4207889
    [No Abstract]   [Full Text] [Related]  

  • 52. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 53. [Influence of fibrinolysis inhibitors on anticoagulant induced hemorrhages].
    Vogel G; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(4):367-75. PubMed ID: 4127132
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
    Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
    Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
    [No Abstract]   [Full Text] [Related]  

  • 55. [Tranexamic acid, a new antifibrinolytic agent].
    Kjellman H; Schannong M
    Nord Med; 1970 Feb; 83(6):166-8. PubMed ID: 4910677
    [No Abstract]   [Full Text] [Related]  

  • 56. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Coagulation physiological bases of antifibrinolytic treatment in prostatectomies].
    Neef H; Preusser KP; Anger G; Richter M
    Zentralbl Chir; 1967 Apr; 92(13):486-90. PubMed ID: 5591468
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inveestigation of the inhibition of fibrinolysis using epsilon-aminocapronic acid].
    Stenszky E; Aszódi L; Hatvani I
    Acta Pharm Hung; 1968 Jun; 38(2):191-6. PubMed ID: 5723266
    [No Abstract]   [Full Text] [Related]  

  • 59. [On the fibrinolytic activity of the plasma of thrombopenic patients and the effect of corticoids and epsilon-aminocaproic acid].
    Pileggi JE
    Sangre (Barc); 1967; 12(4):375-82. PubMed ID: 5614843
    [No Abstract]   [Full Text] [Related]  

  • 60. Control of bleeding during and after prostatectomy.
    Fam A
    Int Surg; 1971 Nov; 56(5):352-61. PubMed ID: 5315847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.